Elenbecestat

N/A

Report date: 2025/12/02 15:15:54
NME

Base Information

Drug NameElenbecestat
Drug Alias NameE-2609
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-secretase 1 inhibitors
TargetsBeta-secretase 1
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaCanada +[29
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesEisai Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEisai Co Ltd
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A